ZALEPLON (Ascend Laboratories, LLC)
Welcome to the PulseAid listing for the ZALEPLON drug offered from Ascend Laboratories, LLC. This gamma-Aminobutyric Acid A Receptor Agonist [EPC],GABA A Agonists [MoA],Central Nervous System Depression [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Ascend Laboratories, LLC |
| NON-PROPRIETARY NAME: | ZALEPLON |
| SUBSTANCE NAME: | ZALEPLON |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | gamma-Aminobutyric Acid A Receptor Agonist [EPC],GABA A Agonists [MoA],Central Nervous System Depression [PE] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2010-12-15 |
| END MARKETING DATE: | 0000-00-00 |
ZALEPLON HUMAN PRESCRIPTION DRUG Details:
| Item Description | ZALEPLON from Ascend Laboratories, LLC |
| LABELER NAME: | Ascend Laboratories, LLC |
| DEA SCHEDULE: | CIV
|
| ACTIVE STRENGTH: | 5(mg/1) |
| START MARKETING DATE: | 2010-12-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 67877-210_2f44db39-e1d9-451e-ba31-e4b10366a430 |
| PRODUCT NDC: | 67877-210 |
| APPLICATION NUMBER: | ANDA078989 |
Other ZALEPLON Pharmaceutical Manufacturers / Labelers:
